As global health officials monitor new Ebola cases, questions are emerging about how the virus is detected, tested, and whether it poses a broader public risk. Medical epidemiologist and board-certified pathologist David A. Schwartz joins us to discuss the challenges in Ebola diagnostics with insights from the outbreak in the Democratic Republic of the Congo.
Why does Ebola remain such a difficult disease to diagnose early, particularly in resource limited outbreak settings?
Ebola virus disease can be difficult to diagnose in endemic areas. Early symptoms are nonspecific and, during the first two to five days of illness, patients often present with fever, fatigue, headache, muscle aches, and sore throat. These symptoms can resemble malaria, typhoid, influenza, shigellosis, meningitis, and other viral hemorrhagic fevers.
Polymerase chain reaction (PCR) testing requires specialized laboratories and biosafety infrastructure, which may not be available in rural outbreak settings. Antigen-based tests can be useful at the point of outbreak and in low-resource settings, but they are generally less sensitive than PCR, particularly early in disease.
Sample handling is another major challenge. Blood, body fluids, and tissue from suspected Ebola patients pose significant biohazard risks and must be collected, transported, and processed under strict containment procedures.
Outbreaks often occur in remote areas with limited health system capacity. High patient volumes can lead to triage delays, personal protective equipment (PPE) shortages, difficulties collecting and transporting samples safely, and laboratory backlogs. Diagnosis may also be delayed when patients present late, including after first seeking care from traditional or local healers.
What are the main laboratory methods currently used to detect Ebola virus infections?
Reverse transcription PCR (RT-PCR) remains the gold-standard test for diagnosing acute Ebola virus infection. It is highly sensitive and specific, capable of detecting viral RNA early in the course of illness, even when viral loads are low.
However, RT-PCR has important logistical limitations. Testing requires specialized laboratory infrastructure and highly trained personnel, while sample collection, handling, and transport must follow strict biosafety protocols because of the significant risks associated with Ebola virus. These requirements can limit access to testing, particularly during outbreaks in remote or resource-limited settings.
How important are turnaround time and access to rapid diagnostics during Ebola outbreaks?
Because of the highly infectious nature of Ebola virus, access to appropriate diagnostic reagents, laboratory infrastructure, and trained personnel is essential for rapid and accurate diagnosis. Timely laboratory testing plays a critical role in patient management, infection control, contact tracing, and outbreak containment, making diagnostic capacity a key component of effective outbreak response.
What diagnostic and surveillance challenges are unique to the current Bundibugyo ebolavirus outbreak in the Ituri Province, Democratic Republic of the Congo?
The current outbreak is affecting rural health zones with limited infrastructure to support outbreak response. Some of the affected areas are also impacted by ongoing conflict, creating additional challenges for disease control. Roadblocks, attacks on healthcare facilities and personnel, and population displacement can hinder contact tracing, active case finding, and the safe burial practices that are essential for containing Ebola outbreaks.
The Africa CDC has also highlighted substantial population movement associated with mining activities in Mongbwalu, which can make it difficult to monitor contacts and may facilitate wider geographic spread of the virus. The outbreak spans several distinct health zones, including Mongbwalu, a mining region; Rwampara, a peri-urban area; and Bunia, a major urban center. This combination of rural, peri-urban, and urban settings complicates surveillance and response efforts, as each area presents different epidemiological and logistical challenges that require tailored public health strategies.
How does Ebola spread within healthcare and community settings, and what role do laboratories play in limiting transmission during outbreaks?
The Ebola virus is transmitted through direct contact with infected body fluids and contaminated surfaces or objects. Healthcare workers are particularly vulnerable, especially during the early stages of an outbreak before the cause of illness has been identified and infection-control measures are fully implemented.
Appropriate PPE is highly effective in preventing transmission in healthcare settings. However, shortages of PPE can significantly increase the risk of infection among healthcare workers, particularly in resource-limited settings where outbreaks often occur.
Based on the current epidemiologic situation, does the Ituri Province outbreak pose a broader regional or international public health risk?
It could act as a source of regional transmission, particularly where populations are highly mobile and international borders are porous. From an international public health perspective, infected travelers in the early or presymptomatic stages of infection may be difficult to identify and diagnose.
How are genomic sequencing and newer molecular technologies changing outbreak investigation and tracking for Ebola and other viral hemorrhagic fevers?
Genomic sequencing and other advanced molecular technologies have transformed the investigation of Ebola outbreaks and other viral hemorrhagic fevers, providing insights that were not possible a decade ago.
These tools can help distinguish between disease relapse caused by a virus genetically identical to a previous infection, reinfection with a different viral lineage, and persistent infection in which the virus continues to evolve through the gradual accumulation of mutations in immune-privileged sites. Such information is critical for understanding transmission patterns, identifying sources of infection, and guiding public health responses.
Looking ahead, what improvements in Ebola diagnostics, surveillance, or outbreak preparedness are still most urgently needed?
Looking ahead, several priorities remain critical: developing faster, field-deployable diagnostic tests capable of detecting multiple filoviruses, including assays specific for Bundibugyo and Sudan ebolaviruses; establishing secure, integrated genomic and epidemiologic surveillance systems that can operate effectively in conflict-affected regions; and expanding access to vaccines, therapeutics, and pre-positioned outbreak response resources for all Ebola virus species, not just the Zaire strain.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
